Citation Impact
Citing Papers
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
2009
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: Analogy between angina pectoris and solid tumors and enhancement of the EPR effect
2010
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
2011
Imaging in the era of molecular oncology
2008 StandoutNature
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Clinical and therapeutical implications of EPC biology in atherosclerosis
2006
Differential drug class‐specific metastatic effects following treatment with a panel of angiogenesis inhibitors
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Coordinated regulation of myeloid cells by tumours
2012 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non-small Cell Lung Cancer
2009
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Lysosomal metabolism of glycoproteins
2005
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games
2005
Oxygen-sensing under the influence of nitric oxide
2009
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Microenvironmental regulation of metastasis
2008 Standout
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
2009
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
2011
The mononuclear phagocyte system
2005
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
2007 Nature
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
2014
Metastatic colonization by circulating tumour cells
2016 StandoutNature
History of myeloid-derived suppressor cells
2013
Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis
2017
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
2006
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Tumor Angiogenesis
2008 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
HIF and the Lung
2011 StandoutNobel
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Effects of Aging and Hypoxia-Inducible Factor-1 Activity on Angiogenic Cell Mobilization and Recovery of Perfusion After Limb Ischemia
2007 StandoutNobel
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
2006
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
2006 Science
Combination therapy in combating cancer
2017 Standout
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
2006
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
2010
Cancer Genome Landscapes
2013 StandoutScience
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
2009
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
PanR1, a Dominant Negative Missense Allele of the Gene Encoding TNF-α (Tnf), Does Not Impair Lymphoid Development
2006 StandoutNobel
Endothelial Function and Dysfunction
2007 Standout
Works of Akio Kanda being referenced
Nitroglycerin treatment may increase response to docetaxel and carboplatin regimen via inhibitions of hypoxia-inducible factor-1 pathway and P-glycoprotein in patients with lung adenocarcinoma
2006
Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models
2005
Immunoelectron microscopic analysis of lysosomal deposits in α-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum
2002
Macrophage Colony-Stimulating Factor Induces Vascular Endothelial Growth Factor Production in Skeletal Muscle and Promotes Tumor Angiogenesis
2005
Increased susceptibility to airway responses in CD40-deficient mice
2003
Randomized Phase II Trial Comparing Nitroglycerin Plus Vinorelbine and Cisplatin With Vinorelbine and Cisplatin Alone in Previously Untreated Stage IIIB/IV Non–Small-Cell Lung Cancer
2006
Nitroglycerin Treatment May Enhance Chemosensitivity to Docetaxel and Carboplatin in Patients with Lung Adenocarcinoma
2006